Unknown

Dataset Information

0

Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.

ABSTRACT: A nationwide laboratory-based surveillance study of invasive S. pyogenes infections was conducted in Germany. Invasive isolates (n = 1,281) were obtained between 2003 and 2013. All isolates were susceptible to penicillin, cefotaxime and vancomycin. Tetracycline showed the highest rate of resistant or intermediate resistant isolates with 9.8%, followed by macrolides (4.0%), trimethoprim/sulfamethoxazole (SXT) (1.9%), levofloxacin (1.3%), chloramphenicol (0.9%) and clindamycin (0.7%). The most prominent trends were the appearance of levofloxacin non-susceptible isolates since 2011, and an increase of SXT non-susceptibility since 2012.

SUBMITTER: Imohl M 

PROVIDER: S-EPMC4560406 | biostudies-other | 2015

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.
| S-EPMC1087656 | biostudies-literature
Unknown Molecular diversity and antimicrobial susceptibility of Listeria monocytogenes isolates from invasive infections in Poland (1997-2013).
| S-EPMC6162231 | biostudies-literature
Unknown Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.
| S-EPMC3367575 | biostudies-literature
Unknown Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014.
| S-EPMC5515411 | biostudies-literature
Unknown Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
| S-EPMC2798512 | biostudies-literature
Unknown Antimicrobial susceptibility patterns, emm type distribution and genetic diversity of Streptococcus pyogenes recovered in Brazil.
| S-EPMC4296499 | biostudies-literature
Unknown MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasive Streptococcus pyogenes isolates.
| S-EPMC2658026 | biostudies-literature
Unknown Cationic antimicrobial peptides disrupt the Streptococcus pyogenes ExPortal.
| S-EPMC3646575 | biostudies-literature
Unknown Antimicrobial Nonsusceptibility of Gram-Negative Bloodstream Isolates, Veterans Health Administration System, United States, 2003-2013<sup>1</sup>.
| S-EPMC5652419 | biostudies-literature
Unknown Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi.
| S-EPMC2759039 | biostudies-literature